Application of Electrolyzed Hydrogen Water for Management of Chronic Kidney Disease and Dialysis Treatment-Perspective View.
Masaaki Nakayama, Shigeru Kabayama, Mariko Miyazaki · Antioxidants (Basel, Switzerland) · 2024
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In participants, to date, while many preclinical studies using H₂ have confirmed organ-protective effects and correction of metabolic abnormalities through its antioxidant and anti-inflammatory effects [ 12, 13, 14, 15, 16, 17, 18 ], no severe side effects of H₂ loading have been observed. These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence inflammatory regulation.
What the Findings Mean
H2HUBB reviewed how multiple hydrogen delivery methods (hydrogen-rich water, gas inhalation) was evaluated in this publication and summarizes the source-grounded findings below. To date, while many preclinical studies using H₂ have confirmed organ-protective effects and correction of metabolic abnormalities through its antioxidant and anti-inflammatory effects [ 12, 13, 14, 15, 16, 17, 18 ], no severe side effects of H₂ loading have been observed.
What the Researchers Studied
The study used a narrative review. The comparison condition was placebo.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen concentration: 1.2 mg/L H₂; Source-reported hydrogen exposure: 1.2 mg/L H₂; reported treatment duration: 3 months. To date, while many preclinical studies using H₂ have confirmed organ-protective effects and correction of metabolic abnormalities through its antioxidant and anti-inflammatory effects [ 12, 13, 14, 15, 16, 17, 18 ], no severe side effects of H₂ loading have been observed. However, histologically, kidney damage was suppressed, and a significant increase in antioxidant substances and a significant decrease in proinflammatory substances were confirmed in rats on hydrogen water compared to the control group. In the hydrogen water-drinking group, Nrf2 expression in cardiac tissues was enhanced, suggesting increased resistance to oxidative stress in the body.
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence inflammatory regulation and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a narrative review. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as human clinical study with human clinical evidence. The reported sample size was 30. The study used a narrative review. The hydrogen delivery method was multiple hydrogen delivery methods (hydrogen-rich water, gas inhalation). The source-reported hydrogen concentration was 1.2 mg/L H₂. The source-reported hydrogen exposure was 1.2 mg/L H₂. The reported treatment duration was 3 months.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.